Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...
The journey of AstraZeneca from struggling pharma lightweight under siege from Pfizer to Britain's most valuable company is ...
The national security adviser of the United States, Jake Sullivan, has met China’s top diplomat Wang Yi as Beijing finds itself embroiled in security rows with key US allies. Japan scrambled ...
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...
Aug. 5, 2024 China has rejected a ruling by a United Nations-backed arbitration panel that negated almost all of Beijing’s historically based claims in the South China Sea. On Tuesday ...
On July 31, GSK released its financial results for the second quarter of 2024, which again beat analysts' expectations by a wide margin. Under Emma Walmsley's leadership, the company is becoming a ...
Beijing has said this week's China-Africa forum will be its largest diplomatic event since the COVID-19 pandemic, with leaders of South Africa, Nigeria, Kenya and other nations confirmed to attend ...
The best times to visit Beijing are from March to May and from September to October. These temperate seasons provide the best climate, not to mention colorful scenery. In contrast, summer brings ...
Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 25 shareholders Insiders have been ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback